skip to main contentNOVA Research Company
NOVA Research Company Header
HomeAbout UsWhat We DoClientsProductsConferencesPress Room
GovernmentCommercial/Other

Selected Commercial/Other Clients


  The Cancer Institute of New Jersey (CINJ)
CINJ The New Jersey Governor's Conference on Effective Partnering in Cancer Research is an initiative cosponsored by the Hon. James E. McGreevey, Governor of New Jersey, and The Cancer Institute of New Jersey (CINJ), a division of the Robert Wood Johnson Medical School and an NCI-designated Comprehensive Cancer Center. This annual conference brings together world leaders in cancer research, including senior NCI staff and representatives of government agencies, academic medical centers, pharmaceutical companies, biotechnology research institutions, and policy groups. Michelle Murray, NOVA's Conference Director, is responsible for budget development and management; program development; site selection; contract negotiation; travel and hotel arrangements; development of promotional materials; coordination of support staff; and working with media consultants. NOVA science and health policy writers document each conference by writing concise summaries and working with NOVA graphic designers to develop and produce colorful newsletters and formal reports.

American Society of Clinical Oncology (ASCO)
ASCO
NOVA staff assisted the American Society of Clinical Oncology (ASCO) in creating survey instruments for its members to evaluate educational meeting issues in the Summer of 2003. We developed a series of online surveys and the accompanying infrastructure to mine collected data. NOVA performed all of the programming, Web formatting (to facilitate online surveys), and designed the backend data structure (including databases) to receive information from members who responded to each online survey. In addition, we set up and sent the e-mail informing the ASCO membership of the survey, hosted the survey at our onsite server, and performed extensive data cleaning and analysis to present the results to ASCO.

Select QDS™ Commercial Clients
QDS Behavioral researchers, data collectors, physicians, educators, business consultants, and others use QDS to develop automated surveys, questionnaires, and forms for many different types of research. QDS™ software is in use throughout the U.S. and abroad in departments of health, hospitals, research institutions, schools of medicine and public health, community outreach organizations, health clinics, research foundations, private businesses, blood centers, addiction centers, nursing schools, and more. Here is a sampling of select QDS™ commercial clients and the studies they perform:

The University of California, San Francisco (UCSF) Prevention Sciences Group, is leading a cross-site evaluation throughout the U.S. in HIV prevention. QDS™ ACASI is being used to administer questionnaires in English and Spanish in 15 major cities. The attitudes, opinions, and behaviors of patients/clients are being recorded to help develop HIV prevention services and programs. Other studies being conducted at UCSF using QDS™ include: Gay Men Relationship Study, Women's Health Study to Encourage HIV/STD Prevention Methods, and an HIV Prevention Survey.

The University of California, Los Angeles (UCLA) Neuropsychiatric Institute Center for Community Health uses QDS™ as its standard for all behavior assessments. Most projects involve the study of HIV/AIDS and STD risks among a variety of populations, including runaway youth, HIV-positive adults, HIV-positive youth and young adults, and children of parents with HIV. The Center uses the QDS™ ACASI module for all interviews and finds it effective for sensitive sections such as drug use and sexual behavior. For interviewer-administered, face-to-face sections, the text-to-speech component is turned off to allow the interviewer to speak to the subject.

The University of Cape Town and the Medical Research Council in South Africa are working with NOVA on a NIDA-funded collaborative research project to continue developing and testing of the HIV/STD risk-of-exposure screen among South African adolescents. QDS™ is being used on this research project to test the reliability and validity (particularly cultural context) of the POSIT and its HIV/STD risk-of-exposure screen supplement in the Afrikaans language using the Handheld Assisted Personal Interview (HAPI™) module on the Pocket PC for administration.

For more information about QDS, please contact QDS Sales at .

  Bringing high-quality technology and inNOVAtion to the global health and research communities
  Contact Us   |   Employment   |   ©2008, NOVA Research Company